Advertisement

Table of Contents

May 01, 1991; Volume 39,Issue 5

You have access
Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado

Molecular Pharmacology May 1991, 39 (5) 587-591;
You have access
Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
N Hershkowitz and M A Rogawski

Molecular Pharmacology May 1991, 39 (5) 592-598;
You have access
Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
M Memo, P Bovolin, E Costa and D R Grayson

Molecular Pharmacology May 1991, 39 (5) 599-603;
You have access
SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi

Molecular Pharmacology May 1991, 39 (5) 604-608;
You have access
Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
R S Sheldon, R J Hill, M Taouis and L M Wilson

Molecular Pharmacology May 1991, 39 (5) 609-614;
You have access
Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
M F Lignon, N Bernad and J Martinez

Molecular Pharmacology May 1991, 39 (5) 615-620;
You have access
A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
T S Guthrie, J Tsuji and J N Wells

Molecular Pharmacology May 1991, 39 (5) 621-624;
You have access
Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
C H Chen, M Vazquez-Padua and Y C Cheng

Molecular Pharmacology May 1991, 39 (5) 625-628;
You have access
Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
K P Gartland, C R Beddell, J C Lindon and J K Nicholson

Molecular Pharmacology May 1991, 39 (5) 629-642;
You have access
Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe

Molecular Pharmacology May 1991, 39 (5) 643-649;
You have access
Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
A C Barton, L E Black and D R Sibley

Molecular Pharmacology May 1991, 39 (5) 650-658;
You have access
Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
D Lévesque and T Di Paolo

Molecular Pharmacology May 1991, 39 (5) 659-665;
You have access
Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
J A Kemp and T Priestley

Molecular Pharmacology May 1991, 39 (5) 666-670;
You have access
12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
B Brüne and V Ullrich

Molecular Pharmacology May 1991, 39 (5) 671-678;
You have access
Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
I N Pessah and I Zimanyi

Molecular Pharmacology May 1991, 39 (5) 679-689;